BibTex format
@article{Krishnan:2025:10.1164/rccm.202410-2036PP,
author = {Krishnan, JA and Cao, B and Chotirmall, SH and Ely, EW and Openshaw, P and Roche, N and Waterer, G},
doi = {10.1164/rccm.202410-2036PP},
journal = {American Journal of Respiratory and Critical Care Medicine},
pages = {1391--1396},
title = {Using the 2024 national academies of science, engineering, and medicine definition of long Covid implications for pulmonary and critical care medicine},
url = {http://dx.doi.org/10.1164/rccm.202410-2036PP},
volume = {211},
year = {2025}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - SARS-CoV-2 emerged in late 2019, leading to the COVID-19 pandemic (1). In the initial months of the pandemic, the number of hospitalizations for respiratory failure caused by acute respiratory distress syndrome increased exponentially, and the global case fatality rate reached 3.4% with large regional variations (2, 3). An unprecedented number of research studies were launched around the globe, aiming to understand and prevent severe acute illness (4–7). Over the past 5 years, the public health impact of acute COVID-19 has evolved considerably, with increases in population-level immunity due to natural infections and the increasing availability of proven effective vaccines, antiviral agents, immunomodulators, monoclonal antibodies, and the ever-changing landscape of SARS-CoV-2 variants with reduced pathogenicity but enhanced immune evasion and infectivity (8–12).
AU - Krishnan,JA
AU - Cao,B
AU - Chotirmall,SH
AU - Ely,EW
AU - Openshaw,P
AU - Roche,N
AU - Waterer,G
DO - 10.1164/rccm.202410-2036PP
EP - 1396
PY - 2025///
SN - 1073-449X
SP - 1391
TI - Using the 2024 national academies of science, engineering, and medicine definition of long Covid implications for pulmonary and critical care medicine
T2 - American Journal of Respiratory and Critical Care Medicine
UR - http://dx.doi.org/10.1164/rccm.202410-2036PP
VL - 211
ER -